Cargando…

The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor

FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Renault, Valérie M., Thekkat, Pramod U., Hoang, Kimmi L., White, Jamie L., Brady, Colleen A., Broz, Daniela Kenzelmann, Venturelli, Ophelia S., Johnson, Thomas M., Oskoui, Philip R., Xuan, Zhenyu, Santo, Evan E., Zhang, Michael Q., Vogel, Hannes, Attardi, Laura D., Brunet, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136551/
https://www.ncbi.nlm.nih.gov/pubmed/21423206
http://dx.doi.org/10.1038/onc.2011.35
_version_ 1782208225937981440
author Renault, Valérie M.
Thekkat, Pramod U.
Hoang, Kimmi L.
White, Jamie L.
Brady, Colleen A.
Broz, Daniela Kenzelmann
Venturelli, Ophelia S.
Johnson, Thomas M.
Oskoui, Philip R.
Xuan, Zhenyu
Santo, Evan E.
Zhang, Michael Q.
Vogel, Hannes
Attardi, Laura D.
Brunet, Anne
author_facet Renault, Valérie M.
Thekkat, Pramod U.
Hoang, Kimmi L.
White, Jamie L.
Brady, Colleen A.
Broz, Daniela Kenzelmann
Venturelli, Ophelia S.
Johnson, Thomas M.
Oskoui, Philip R.
Xuan, Zhenyu
Santo, Evan E.
Zhang, Michael Q.
Vogel, Hannes
Attardi, Laura D.
Brunet, Anne
author_sort Renault, Valérie M.
collection PubMed
description FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the functional interaction between FoxO and p53 have not been fully explored. Here, we show that p53 transactivates the expression of FoxO3, one of the four mammalian FoxO genes, in response to DNA damaging agents in both mouse embryonic fibroblasts and in thymocytes. We show that p53 transactivates FoxO3 in cells by binding to a site in the second intron of the FoxO3 gene, a genomic region recently found to be associated with extreme longevity in humans. While FoxO3 is not necessary for p53-dependent cell cycle arrest, FoxO3 appears to modulate p53-dependent apoptosis. We also find that FoxO3 loss does not interact with p53 loss for tumor development in vivo, although the tumor spectrum of p53 deficient mice may be affected by FoxO3 loss. Our findings indicate that FoxO3 is a p53 target gene, and suggest that FoxO3 and p53 are part of a regulatory transcriptional network that may play an important role during aging and cancer.
format Online
Article
Text
id pubmed-3136551
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-31365512012-01-21 The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor Renault, Valérie M. Thekkat, Pramod U. Hoang, Kimmi L. White, Jamie L. Brady, Colleen A. Broz, Daniela Kenzelmann Venturelli, Ophelia S. Johnson, Thomas M. Oskoui, Philip R. Xuan, Zhenyu Santo, Evan E. Zhang, Michael Q. Vogel, Hannes Attardi, Laura D. Brunet, Anne Oncogene Article FoxO transcription factors play a conserved role in longevity and act as tissue-specific tumor suppressors in mammals. Several nodes of interaction have been identified between FoxO transcription factors and p53, a major tumor suppressor in humans and mice. However, the extent and importance of the functional interaction between FoxO and p53 have not been fully explored. Here, we show that p53 transactivates the expression of FoxO3, one of the four mammalian FoxO genes, in response to DNA damaging agents in both mouse embryonic fibroblasts and in thymocytes. We show that p53 transactivates FoxO3 in cells by binding to a site in the second intron of the FoxO3 gene, a genomic region recently found to be associated with extreme longevity in humans. While FoxO3 is not necessary for p53-dependent cell cycle arrest, FoxO3 appears to modulate p53-dependent apoptosis. We also find that FoxO3 loss does not interact with p53 loss for tumor development in vivo, although the tumor spectrum of p53 deficient mice may be affected by FoxO3 loss. Our findings indicate that FoxO3 is a p53 target gene, and suggest that FoxO3 and p53 are part of a regulatory transcriptional network that may play an important role during aging and cancer. 2011-03-21 2011-07-21 /pmc/articles/PMC3136551/ /pubmed/21423206 http://dx.doi.org/10.1038/onc.2011.35 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Renault, Valérie M.
Thekkat, Pramod U.
Hoang, Kimmi L.
White, Jamie L.
Brady, Colleen A.
Broz, Daniela Kenzelmann
Venturelli, Ophelia S.
Johnson, Thomas M.
Oskoui, Philip R.
Xuan, Zhenyu
Santo, Evan E.
Zhang, Michael Q.
Vogel, Hannes
Attardi, Laura D.
Brunet, Anne
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title_full The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title_fullStr The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title_full_unstemmed The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title_short The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
title_sort pro-longevity gene foxo3 is a direct target of the p53 tumor suppressor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136551/
https://www.ncbi.nlm.nih.gov/pubmed/21423206
http://dx.doi.org/10.1038/onc.2011.35
work_keys_str_mv AT renaultvaleriem theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT thekkatpramodu theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT hoangkimmil theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT whitejamiel theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT bradycolleena theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT brozdanielakenzelmann theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT venturelliophelias theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT johnsonthomasm theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT oskouiphilipr theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT xuanzhenyu theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT santoevane theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT zhangmichaelq theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT vogelhannes theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT attardilaurad theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT brunetanne theprolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT renaultvaleriem prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT thekkatpramodu prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT hoangkimmil prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT whitejamiel prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT bradycolleena prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT brozdanielakenzelmann prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT venturelliophelias prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT johnsonthomasm prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT oskouiphilipr prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT xuanzhenyu prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT santoevane prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT zhangmichaelq prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT vogelhannes prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT attardilaurad prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor
AT brunetanne prolongevitygenefoxo3isadirecttargetofthep53tumorsuppressor